NEW YORK (GenomeWeb) – Karius has raised $50 million in a Series A financing round led by Data Collective and Lightspeed Venture Partners. New investors Tencent and Khosla Ventures, as well as existing investors Innovation Endeavors and Spectrum 28, also participated.

The Redwood City, California-based firm, which spun out from Stanford University in 2014, said it plans to use the funding to support new and ongoing clinical trials, scale up its laboratory capacity, and help commercialize its infectious disease test.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Jun
05

This webinar will discuss how Sanofi used literature mining to annotate the association of human leukocyte antigen (HLA) alleles with diseases and drug hypersensitivity as part of a multiple sclerosis (MS) biomarker discovery project.

Jun
19

This webinar will provide evidence for the use of RNA in situ hybridization (RNA ISH) as a replacement for immunohistochemistry (IHC) in cancer research and diagnostic applications.